APA

Arnould S., Rodier G., Matar G., Vincent C., Pirot N., Delorme Y., Berthet C., Buscail Y., Noël J. Y., Lachambre S., Jarlier M., Bernex F., Delpech H., Vidalain P. O., Janin Y. L., Theillet C. & Sardet C. (2017). Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition. : Oncotarget.

Chicago

Arnould Stéphanie, Rodier Geneviève, Matar Gisèle, Vincent Charles, Pirot Nelly, Delorme Yoann, Berthet Charlène, Buscail Yoan, Noël Jean Yohan, Lachambre Simon, Jarlier Marta, Bernex Florence, Delpech Hélène, Vidalain Pierre Olivier, Janin Yves L, Theillet Charles and Sardet Claude. 2017. Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition. : Oncotarget.

Harvard

Arnould S., Rodier G., Matar G., Vincent C., Pirot N., Delorme Y., Berthet C., Buscail Y., Noël J. Y., Lachambre S., Jarlier M., Bernex F., Delpech H., Vidalain P. O., Janin Y. L., Theillet C. and Sardet C. (2017). Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition. : Oncotarget.

MLA

Arnould Stéphanie, Rodier Geneviève, Matar Gisèle, Vincent Charles, Pirot Nelly, Delorme Yoann, Berthet Charlène, Buscail Yoan, Noël Jean Yohan, Lachambre Simon, Jarlier Marta, Bernex Florence, Delpech Hélène, Vidalain Pierre Olivier, Janin Yves L, Theillet Charles and Sardet Claude. Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition. : Oncotarget. 2017.